Cyteir Therapeutics Inc. (CYT) NASDAQ

$2.50 -0.05 (-1.96%)

Market Cap: $88.53M

As of 08/16/22 04:00 PM EDT. Market closed.

(CYT)

Cyteir Therapeutics Inc. (CYT) NASDAQ

$2.50 -0.05 (-1.96%)

Market Cap: $88.53M

As of 08/16/22 04:00 PM EDT. Market closed.

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and ... read more

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
31
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$2.55
Days Range
$2.41 - $2.57
52 week range
$1.56 - $21.69
Volume
120,415
Avg. Volume (30 days)
69,555
Market Cap
$88.53M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,413,426
Open
$0
Previous Close
$2.55
Days Range
$2.41 - $2.57
52 week range
$1.56 - $21.69
Volume
120,415
Avg. Volume (30 days)
69,555
Market Cap
$88.53M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,413,426

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CYTEIR THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Novo Holdings A/S 10% Owner Jul 20, 2022 Sale $3.00 900,000 2,700,000 3,940,413 Jul 22, 2022, 06:52 PM
Zakrzewski Joseph S Director May 12, 2022 Buy $1.61 743 1,196 133,416 May 16, 2022, 04:24 PM
THERO JOHN F Director May 10, 2022 Buy $2.00 10,000 20,000 10,000 May 12, 2022, 04:38 PM
Zakrzewski Joseph S Director May 11, 2022 Buy $1.70 1,000 1,700 132,673 May 12, 2022, 04:35 PM
Zakrzewski Joseph S Director May 10, 2022 Buy $1.89 49,406 93,377 131,673 May 12, 2022, 04:35 PM
Zakrzewski Joseph S Director Dec 27, 2021 Buy $10.04 299 3,002 81,666 Dec 28, 2021, 06:24 PM
Zakrzewski Joseph S Director Dec 23, 2021 Buy $9.87 200 1,974 81,367 Dec 28, 2021, 06:24 PM
Zakrzewski Joseph S Director Dec 28, 2021 Buy $9.85 601 5,920 82,267 Dec 28, 2021, 06:24 PM
Zakrzewski Joseph S Director Dec 17, 2021 Buy $9.88 200 1,976 81,167 Dec 21, 2021, 06:06 PM
Zakrzewski Joseph S Director Dec 15, 2021 Buy $10.77 3,700 39,844 80,967 Dec 15, 2021, 08:09 PM
Naesens Janwillem Director Jun 22, 2021 Buy $18.00 277,777 4,999,986 3,536,803 Jun 24, 2021, 08:50 PM
Novo Holdings A/S 10% Owner Jun 22, 2021 Buy $18.00 277,777 4,999,986 4,840,413 Jun 23, 2021, 05:18 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Novo Holdings A/S 10% Owner 07/20/2022 2,700,000
Zakrzewski Joseph S Director 05/12/2022 1,196
THERO JOHN F Director 05/10/2022 20,000
Zakrzewski Joseph S Director 05/11/2022 1,700
Zakrzewski Joseph S Director 05/10/2022 93,377
Zakrzewski Joseph S Director 12/27/2021 3,002
Zakrzewski Joseph S Director 12/23/2021 1,974
Zakrzewski Joseph S Director 12/28/2021 5,920
Zakrzewski Joseph S Director 12/17/2021 1,976
Zakrzewski Joseph S Director 12/15/2021 39,844
Naesens Janwillem Director 06/22/2021 4,999,986
Novo Holdings A/S 10% Owner 06/22/2021 4,999,986
Load More Insider Transactions